{
  "schema_version": 1,
  "kind": "condition",
  "id": "tinnitus",
  "name": "Subjective tinnitus",
  "category": "chronic",
  "sources": "NICE Guideline NG155 · Egyptian National Drug Formulary - Nervous System Disorders 2025 · Stugeron (cinnarizine) 15 mg tablets SmPC sections 4.2 and 4.4 (eMC product 371)",
  "review_status": "reviewed",
  "verified_against": "Egyptian National Drug Formulary - Nervous System Disorders 2025 · Stugeron (cinnarizine) 15 mg tablets SmPC sections 4.2 and 4.4 (eMC product 371)",
  "verified_date": "2026-08",
  "treatments": [
    {
      "id": 1732,
      "generic": "Cinnarizine",
      "line": 1,
      "is_adjunct": false,
      "form": "oral.solid",
      "strength_mg": 25.0,
      "adult_dose": "2 tablets 2 hours before you travel and 1 tablet every 8 hours during your journey.",
      "adult_duration": null,
      "dose_source": "Stugeron (cinnarizine) 15 mg tablets SmPC sections 4.2 and 4.4 (eMC product 371)",
      "rationale": "Alternative labyrinthine sedative and microvascular circulation enhancer",
      "cautions": [
        "May induce extrapyramidal symptoms or parkinsonism in elderly patients with long-term use.",
        "The UK label covers motion sickness only - 2 tablets two hours before travelling, then 1 every 8 hours. Using 15-30 mg three times daily for vestibular symptoms sits outside it, on continental labelling.",
        "Drowsiness, particularly at the start. No driving until they know how it takes them.",
        "Avoid in porphyria.",
        "In patients with Parkinson's disease, Stugeron should only be given if the advantages outweigh the possible risk of aggravating this disease.",
        "Drowsiness and anticholinergic side effects are common."
      ],
      "peds_mgkg_low": null,
      "peds_mgkg_high": null,
      "peds_max_mg": null,
      "peds_basis": null,
      "peds_unit": null,
      "peds_note": "Children 5 to 12 years: One half the adult dose.",
      "peds_min_weight_kg": null,
      "peds_max_weight_kg": null,
      "peds_age_min_months": null,
      "peds_age_max_months": null,
      "peds_age_bands": [
        {
          "label": "5 to 12 years",
          "age_min_months": 60,
          "age_max_months": 155,
          "dose_text": "One half the adult dose."
        }
      ],
      "peds_doses": null,
      "brands": [
        {
          "trade_name": "CEREBAL 25 MG 20 TABS.",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "ALEXANDRIA",
          "price_egp": 16.0,
          "pack_count": 20,
          "unit_price": 0.8,
          "strength_mg": 25.0,
          "exact_strength": true,
          "exact_form": true,
          "discontinued": false,
          "also_contains": null
        },
        {
          "trade_name": "STUGERON 25 MG 30 TAB.",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "MINA PHARM > JANSSEN CILAG",
          "price_egp": 34.5,
          "pack_count": 30,
          "unit_price": 1.15,
          "strength_mg": 25.0,
          "exact_strength": true,
          "exact_form": true,
          "discontinued": false,
          "also_contains": null
        },
        {
          "trade_name": "CINNARIZINE 25MG 20 TAB.",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "ARAB DRUG COMPANY (ADCO)",
          "price_egp": 24.0,
          "pack_count": 20,
          "unit_price": 1.2,
          "strength_mg": 25.0,
          "exact_strength": true,
          "exact_form": true,
          "discontinued": false,
          "also_contains": null
        }
      ],
      "condition_id": "tinnitus"
    }
  ]
}